Table 2: Baseline Clinical and Fasting Laboratory Characteristics of Female Patients with Type 2 Diabetes Mellitus

Group A (n=19) Group B (n=30) p
Hypertension (%) 63.2 83.3 ns
Statin use (%) 52.6 56.7 ns
CVD (%) 21.1 16.7 ns
Smoking (%) 31.6 13.3 ns
Age (years) 61.8±11.4 64.5±6.6 ns
Weight (kg) 69.1±19.4 75.3±14.2 ns
Height (m) 1.6±0.1 1.6±0.1 ns
BMI (kg/m2) 27.1±7.2 31±4.9 0.009
Waist circumference (cm) 96.6±16.8 105.8±13 ns
Body fat (%) 41±7.9 50.7±7.9 <0.001
Duration of diabetes (years) 11.3±6 9.7±6.8 ns
SBP (mmHg) 141.1±19.8 136.3±16.6 ns
DBP(mmHg) 85.8±13.1 75.7±11.4 0.013
WCC (x103/µl) 7799±3277 7132±1551 ns
Uric acid (mg/dl) 4.5±1.6 5.5±1.4 ns
TC (mg/dl) 222±45 192±41 0.022
TG (mg/dl) 160
(69-620)
129
(69-542)
ns
HDL-C (mg/dl) 58±18 49±12 ns
LDL-C (mg/dl) 125±41 113±33 ns
AST (u/l) 20±12 21±6 ns
ALT (u/l) 24±17 24±15 ns
CK (u/l) 60±27 82±36 ns
Gamma-GT (u/l) 17
(12-120)
15
(10-53)
ns
Glucose (mg/dl) 232±59 136±35 N/A
HbA1c (%) 10.3±1.7 6.2±0.7 N/A
Cr (mg/dl) 0.8±0.3 0.8±0.2 ns
Leptin (ng/ml) 14.3±8.8 17.8±8.1 ns
Adiponectin (µg/ml) 15.9±8.4 16.8±11.1 ns
Ghrelin (pg/ml) 934±245 809±314 0.019
NPY (pmol/L) 186.1±71.9 140.9±45.7 0.021
MDRD eGFR (mL/min/1.73m2) 82.8±30.9 88.6±28.2 ns
Cockroft-Gault creatinine clearance (mL/min) 87.2±54.5 95.8±38.4 ns

For abbreviations see Table 1.